amiodarone has been researched along with Hyperpotassemia in 5 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This in-vitro study of human erythrocytes was designed to determine whether amiodarone could attenuate fluoride-induced hyperkalemia." | 7.72 | Amiodarone attenuates fluoride-induced hyperkalemia in vitro. ( Chu, J; Hoffman, RS; Howland, MA; Nelson, LS; Su, M, 2003) |
| "Amiodarone was effective in preventing VT recurrence." | 5.30 | Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report. ( Akiyama, J; Morishima, A; Tomizawa, T; Umezawa, S, 1999) |
| "This in-vitro study of human erythrocytes was designed to determine whether amiodarone could attenuate fluoride-induced hyperkalemia." | 3.72 | Amiodarone attenuates fluoride-induced hyperkalemia in vitro. ( Chu, J; Hoffman, RS; Howland, MA; Nelson, LS; Su, M, 2003) |
| "Amiodarone was effective in preventing VT recurrence." | 1.30 | Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report. ( Akiyama, J; Morishima, A; Tomizawa, T; Umezawa, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jadoul, M | 1 |
| Thumma, J | 1 |
| Fuller, DS | 1 |
| Tentori, F | 1 |
| Li, Y | 1 |
| Morgenstern, H | 1 |
| Mendelssohn, D | 1 |
| Tomo, T | 1 |
| Ethier, J | 1 |
| Port, F | 1 |
| Robinson, BM | 1 |
| Su, M | 1 |
| Chu, J | 1 |
| Howland, MA | 1 |
| Nelson, LS | 1 |
| Hoffman, RS | 1 |
| Akiyama, J | 1 |
| Tomizawa, T | 1 |
| Umezawa, S | 1 |
| Morishima, A | 1 |
| Campbell, TJ | 1 |
| Wyse, KR | 1 |
| Hemsworth, PD | 1 |
| Alvarez, A | 1 |
| Sáenz, L | 1 |
| Oliveras, C | 1 |
| Llordes, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Mathematical Model for the Evaluation of the Potassium Kinetic During and After Hemodialysis for the Potassium Profiling in the Dialysate to Prevent Arrhythmias[NCT04563091] | 6 participants (Anticipated) | Interventional | 2018-11-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for amiodarone and Hyperpotassemia
| Article | Year |
|---|---|
Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dialysis Sol | 2012 |
Amiodarone attenuates fluoride-induced hyperkalemia in vitro.
Topics: Amiodarone; Humans; Hyperkalemia; In Vitro Techniques; Potassium; Potassium Channel Blockers; Quinid | 2003 |
Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report.
Topics: Acute Kidney Injury; Amiodarone; Anti-Arrhythmia Agents; Humans; Hyperkalemia; Male; Middle Aged; My | 1999 |
Effects of hyperkalemia, acidosis, and hypoxia on the depression of maximum rate of depolarization by class I antiarrhythmic drugs in guinea pig myocardium: differential actions of class Ib and Ic agents.
Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Electric Stimulation; Elec | 1991 |
[Electrocardiographic changes caused by ionic disorders and drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Digitalis; Education, Medical, Continuing; Electrocardiogra | 1990 |